QuintilesIMS Real-World Insights Bibliography

The cost-effectiveness of travoprost preserved with polyquad® in newly treated open-angle glaucoma patients in 7 Asian countries.
Author(s): Gerlier L1, Lamotte M1, Caputo J2, Tan R3
Affiliations(s): 1 IMS Health Consulting EMEA, Vilvoorde, Belgium 2 IMS Health Consulting Asia-Pacific, Singapore 3 ALCON, Asia-Pacific, Singapore
Publication(s): 5th ISPOR Asia-Pacific Conference, 2012, September 2-4, Taipei, Taiwan
Document Type(s): Abstract, Poster
Countries: India, Malaysia, Singapore, South Korea, Thailand
C:
Y:
Ophthalmology
2012
  L:
A:
English
Cost effectiveness
  Add to report
 
 
Medical resource use and associated costs in open-angle glaucoma in 10 Asia-pacific countries.
Author(s): Gerlier L1, Lamotte M1, Caputo J2, Tan R3
Affiliations(s): 1 IMS Health Consulting EMEA, Vilvoorde, Belgium 2 IMS Health Consulting Asia-Pacific, Singapore 3 ALCON, Asia-Pacific, Singapore
Publication(s): 5th ISPOR Asia-Pacific Conference, 2012, September 2-4, Taipei, Taiwan
Document Type(s): Abstract, Poster
Countries: Australia, China, Hong Kong, India, Malaysia, New Zealand, Singapore, South Korea, Taiwan, Thailand
C:
Y:
Ophthalmology
2012
  L:
A:
English
Burden of illness
  Add to report
 
 
Modelling the cost-effectiveness of acarbose in preventing type 2 diabetes in a South Korean setting
Author(s): JongMann K1, Clegg JP2, Chang K1, JuYeol P1, Wittrup-Jensen KU3, Palmer AJ2, Roze S2, Valentine WJ2
Affiliations(s): 1Bayer, Seoul, South Korea, 2IMS Health, Allschwil, Switzerland, 3Bayer Schering Pharma AG, Berlin, Germany,
Publication(s): ISPOR 3rd Asia-Pacific Conference
Document Type(s): Oral presentation
Countries: South Korea
C:
Y:
Diabetes
2008
  L:
A:
English
Cost effectiveness
  Add to report